Reata Pharmaceuticals, Inc. (RETA) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Last update: 07:00 PM EST

Day's range

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date	Details
08/08/2022	Goldman Sachs	Madhu Kumar	$76.00	$24.13	214.96%

Reata Pharmaceuticals, Inc. FAQ's

Reata Pharmaceuticals, Inc. has been rated by research analysts at Goldman Sachs, Robert W. Baird, Citigroup in the past 90 days.

New Alert

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.

Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.

In future if you don't want to receive any email then delete stocks added into alert section.

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.